Morgan Stanley
CO

Morgan Stanley’s Global Cord Blood Corporation CO Stock Holding History

Morgan Stanley’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-87,064
Closed -$260K – 7848
2023
Q1 		$260K Hold
87,064
– – ﹤0.01% 5584
2022
Q4 		$260K Sell
87,064
-63
-0.1% -$188 ﹤0.01% 5559
2022
Q3 		$260K Sell
87,127
-12,633
-13% -$31K ﹤0.01% 5599
2022
Q2 		$295K Buy
99,760
+80,769
+425% +$250K ﹤0.01% 5697
2022
Q1 		$73K Buy
18,991
+16,660
+715% +$69.2K ﹤0.01% 6504
2021
Q4 		$10K Buy
2,331
+42
+2% +$178 ﹤0.01% 7488
2021
Q3 		$11K Sell
2,289
-222
-9% -$1.09K ﹤0.01% 7307
2021
Q2 		$13K Sell
2,511
-171,950
-99% -$900K ﹤0.01% 7175
2021
Q1 		$790K Buy
174,461
+2,963
+2% +$12.9K ﹤0.01% 4876
2020
Q4 		$636K Sell
171,498
-4,855
-3% -$18.6K ﹤0.01% 4927
2020
Q3 		$624K Sell
176,353
-34,917
-17% -$121K ﹤0.01% 4527
2020
Q2 		$655K Sell
211,270
-3,146
-1% -$9.14K ﹤0.01% 4461
2020
Q1 		$682K Buy
214,416
+68,735
+47% +$301K ﹤0.01% 4201
2019
Q4 		$728K Sell
145,681
-35,401
-20% -$169K ﹤0.01% 4722
2019
Q3 		$876K Buy
+181,082
New +$950K ﹤0.01% 4373
2019
Q2 		– Sell
-26
Closed – – 6934
2019
Q1 		$0 Buy
+26
New +$172 ﹤0.01% 6917
2018
Q3 		– Sell
-502
Closed -$5K – 6995
2018
Q2 		$5K Sell
502
-70,248
-99% -$673K ﹤0.01% 6456
2018
Q1 		$722K Buy
70,750
+43,286
+158% +$442K ﹤0.01% 4770
2017
Q4 		$273K Sell
27,464
-168,683
-86% -$1.84M ﹤0.01% 5295
2017
Q3 		$2.18M Buy
196,147
+181,192
+1,212% +$2.12M ﹤0.01% 3799
2017
Q2 		$142K Buy
14,955
+8,362
+127% +$66.7K ﹤0.01% 5494
2017
Q1 		$44K Sell
6,593
-151
-2% -$895 ﹤0.01% 5870
2016
Q4 		$41K Sell
6,744
-804
-11% -$4K ﹤0.01% 5807
2016
Q3 		$39K Hold
7,548
– – ﹤0.01% 5689
2016
Q2 		$43K Hold
7,548
– – ﹤0.01% 5576
2016
Q1 		$46K Hold
7,548
– – ﹤0.01% 5647
2015
Q4 		$48K Hold
7,548
– – ﹤0.01% 5733
2015
Q3 		$45K Sell
7,548
-10,521
-58% -$65.4K ﹤0.01% 5778
2015
Q2 		$111K Buy
18,069
+4,049
+29% +$24.9K ﹤0.01% 5534
2015
Q1 		$72K Sell
14,020
-58,291
-81% -$287K ﹤0.01% 5663
2014
Q4 		$327K Sell
72,311
-85,356
-54% -$405K ﹤0.01% 4955
2014
Q3 		$771K Buy
157,667
+119,398
+312% +$579K ﹤0.01% 4263
2014
Q2 		$211K Sell
38,269
-4,067
-10% -$18.3K ﹤0.01% 5128
2014
Q1 		$170K Sell
42,336
-4,097
-9% -$16.7K ﹤0.01% 5190
2013
Q4 		$186K Buy
46,433
+14,085
+44% +$56.1K ﹤0.01% 5062
2013
Q3 		$123K Buy
32,348
+7,940
+33% +$29.9K ﹤0.01% 5040
2013
Q2 		$69K Buy
+24,408
New +$69.6K ﹤0.01% 5148

Other funds holding CO

Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
OA
Operose Advisors Milwaukee, Wisconsin $431M AUM 20.45% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Morgan Stanley's CO Position: Q2 2023 in Review

Morgan Stanley sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 87,064 shares — an estimated $260K sold.

Morgan Stanley first reported a position in CO in Q2 2013 and held it in 37 quarters. The position peaked at $2.18M in Q3 2017. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.

  • Morgan Stanley reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 87,064 Global Cord Blood Corporation shares in Q2 2023, an estimated $260K.
  • Morgan Stanley first reported a position in Global Cord Blood Corporation in Q2 2013 and held it in 37 quarters.
  • Morgan Stanley's Global Cord Blood Corporation position peaked at $2.18M in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.